Peculiarities of Long COVID-19 and Treatment Strategy: A Clinical Case

    December 2021 in “ Zenodo (CERN European Organization for Nuclear Research) ”
    Volyansky, A. Yu., Davydova, T. V., Kuchma, I. Yu., Kuchma, M.V., Yudin, I.P.
    TLDR Long-COVID can cause lasting symptoms, but treatment with Erbisol drugs may help.
    The document discussed a clinical case of a 25-year-old patient who experienced long-COVID-19 symptoms, including headaches, impaired concentration, panic attacks, and joint pain, after recovering from an acute COVID-19 infection. The patient was diagnosed with post-COVID syndrome and reactive arthritis, and was treated with Erbisol drugs, which led to an improvement in symptoms and normalization of immunological parameters. The study highlighted the need for further research into the mechanisms of post-COVID syndrome and suggested that immunocorrection therapy could be beneficial in managing post-viral inflammation and secondary autoimmune disorders.
    Discuss this study in the Community →